Eli Lilly Prepares to Launch Obesity and Diabetes Drug Tirzepatide in India by 2025
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Eli Lilly
Read More
Novo Nordisk India Urges Early Wegovy Launch Amid Competition Concerns
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….
- 1
- 2